WHO says the outbreak is still expanding — and that same day, we get the first real treatment hope for this strain. Quick reset if you're just tuning in: Bundibugyo is the strain driving this DRC-Uganda response, and the toolkit is thin — no licensed vaccine, no curative treatment, unlike Zaire ebolavirus. Scientists, including Jean-Jacques Muyembe, have stressed that delayed recognition is still a practical problem, because the bleeding symptoms can be subtle. So diagnostics, clinical care, and research stay right at the center of the plan. This is Ebola Watch. Two signals pulling in opposite directions — a treatment finally in view, and an outbreak that won't sit still. Plus, a cross-border drill in Mombasa we've been waiting on. Let's start with WHO's word: expanding. If Bundibugyo medical tools access matters to you, hit follow — we'll be back on it soon. This one comes via The Jerusalem Post. The word from WHO today is 'expanding.' That doesn't automatically mean it's accelerating, and it doesn't mean it's plateauing. On a transmission curve, it means the case count is still pushing outward. It doesn't tell us how fast, or what the next two weeks look like. Okay, but let's sit with that for a second. Monday, we read out the epi weeks, the nerve centre got its ribbon cut, the EU money landed — and WHO's answer this week is: still growing. Both things can be true, Daniel. Money and infrastructure don't flip a curve overnight — they change what happens six, eight weeks downstream. Today's snapshot looks worse; the response momentum shows up later, if it shows up at all. And the piece that keeps nagging me — 628 people were in isolation last time we checked. If it's still expanding, that cohort's bigger now, which means the fatality ratio everyone's quoting is still soft. Exactly. You can't lock in a case-fatality figure while the denominator is still moving. 'Expanding' is exactly when you read that number loosely, not repeat it like it's settled. Here's Jonathan Lambert at KGOU:
That reality is changing. Clinical trials are underway, or soon will be, to test new tools that health officials hope could help turn the tide against an outbreak that has already killed over 500 people and sickened more than 1,560 — and which some say could become the largest Ebola outbreak ever.
Here's what that word 'hope' is carrying: the first patients have been enrolled in a clinical trial testing two drugs against the Bundibugyo strain specifically. We're talking about this strain — the one with an empty shelf — rather than the Zaire strain, which already has licensed treatments. Okay, but I need you to define 'hope' in a timeline, Cera. Because a parent of a Peace Corps volunteer hears 'clinical trial' and needs to know — is that hope this year, or hope in 2031? Honest answer — enrollment just started. Amanda Rojek at Oxford says they urgently need these treatments, which tells you they don't have them yet. We're talking about a candidate in early trials, not a drug on a truck to Goma. Fifty days in. Fifty. And we just enrolled the first patients. Right after we heard WHO say the thing is still expanding. That's the gap I'd plant a flag in. 'Hope' is in the Oxford lab. 'Dose in hand' is in Butembo. And the distance between those two changes by the day in an outbreak like this. The Bundibugyo tools gap has an actual next step now — trials aimed at this strain. That matters. I'm just not going to pretend the timeline has caught up to the curve. From Farhiya Hussein at The Eastleigh Voice:
Eastern African countries have intensified efforts to strengthen preparedness for cross-border disease outbreaks following a four-day regional emergency response workshop and simulation exercise held in Mombasa by the Africa Centres for Disease Control and Prevention (Africa CDC). The exercise brought together public health experts and emergency response officials from Kenya, Ethiopia, South Sudan, Sudan, Djibouti and Zanzibar, alongside representatives from regional organisations and international health partners, to improve coordination during public health emergencies.
So all week I've been asking what 'cross-border coordination' actually means when a sick contact walks from one country into the next. Africa CDC just ran a four-day answer in Mombasa. Kenya, Ethiopia, South Sudan, Sudan, Djibouti, Zanzibar — around the table for a simulation exercise, not just a communiqué. That's the piece that matters to me: they rehearsed the handoff instead of only pledging to do it. And notice who's not in that room, Cera. Uganda's the one actually fighting Bundibugyo right now, and the exercise is happening next door in Kenya. Right — the outbreak is why they're drilling, but it's the neighbors getting ready in case it arrives. The question I'd put to them is: did everyone in that room use the same case definition? Because a simulation only works if a suspected case in Djibouti means the same thing as a suspected case in Juba. And that's my worry — you can run a beautiful four-day workshop and still fumble the real thing if the paperwork doesn't line up at the actual border post. If Ebola Watch helps you keep up with fast-moving public health news, try Hantavirus Watch: daily updates on the 2026 outbreak, including the MV Hondius Andes-virus cluster, CDC and WHO response, contact tracing, and traveler risk. Find it wherever you listen to podcasts.
We've put links to every story from today's briefing in the show notes, so if there's a development you want to dig into further, that's the place to start.
That's Ebola Watch for today. This is a Lantern Podcast.